Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.

Acta virologica - 1 Jan 2001

Husa P, Chalupa P, Stroblová H, Husová L, Slesinger P

Abstract excerpt

The aim of this study was to evaluate the efficacy of alpha-interferon (alpha-IFN) treatment of 56 chronic hepatitis B (HB) patients positive for HB e antigen (HBeAg), which were previously not treated with alpha-IFN (group A). Seven of them, which did not respond to initial alpha-IFN treatment, were subjected to additional treatment with alpha-IFN (group B). Another 7 patients with chronic HB caused apparently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B, Chronic

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Interferon-alpha

Share to Mutation

Share to Viremia

Source

Identifiers

PMID: 12083328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.PMID 12083328Read ↗

Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.Semantic proximity Read ↗

Short- and long-term outcome of interferon therapy for chronic hepatitis B infection.Semantic proximity Read ↗

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma.Semantic proximity Read ↗

Interferon Therapy of Chronic Hepatitis BSemantic proximity Read ↗

Hepatitis B genotypes and the response to interferon therapy.Semantic proximity Read ↗

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group.Semantic proximity Read ↗

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.Semantic proximity Read ↗

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

Efficacy of chronic hepatitis C therapy with interferon alpha (IFN-alpha) in Slovenia.Semantic proximity Read ↗

Extended duration of treatment with peginterferon alfa-2a in patients with chronic hepatitis B, HBeAg-negative and E genotype: A retrospective analysis.Semantic proximity Read ↗

Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan.Semantic proximity Read ↗

Alpha interferon treatment in chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.